The results of two phase 3 trials investigating Survodutide, a weight loss drug from Boehringer Ingelheim, suggest that the ...

But with GLP-1 drugs, she said, “everyone is kind of iterating in real time.” Here’s what we’ve learned in the process. At ...

Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested. The research, which was published in The BMJ, found that stopping the ...

See more of our coverage in your search results. Add The New York Post on Google Another win for the jab. Now new research out of Israel has found that it can substantially reduce the risk of ...

AstraZeneca Plc’s obesity pill helped patients lose as much as 11.8% of their body weight in a study that puts it roughly on ...

In the Ozempic era, not all pounds lost are met with praise. New research suggests that people may face more judgment for slimming down with the help of a GLP-1 drug than if they hadn’t lost weight at ...